Influence of inflammation and atrophy on pancreatic secretory trypsin inhibitor levels within the gastric mucosa
- 1 March 1994
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 106 (3) , 735-741
- https://doi.org/10.1016/0016-5085(94)90709-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.Gut, 1991
- Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice.Gut, 1990
- Primary structure of human pancreatic secretory trypsin inhibitor (PSTI) geneBiochemical and Biophysical Research Communications, 1987
- Competition of a growth stimulating-/cholecystokinin (CCK) releasing-peptide (monitor peptide) with epidermal growth factor for binding to 3T3 fibroblastsBiochemical and Biophysical Research Communications, 1987
- Immunohistochemical localization of pancreatic secretory trypsin inhibitor in fetal and adult pancreatic and extrapancreatic tissues.Journal of Histochemistry & Cytochemistry, 1986
- The Role of Mucus in the Protection of the Gastroduodenal MucosaScandinavian Journal of Gastroenterology, 1986
- The use of avidin-biotin interaction in immunoenzymatic techniques.Journal of Histochemistry & Cytochemistry, 1979
- The antrum in patients with duodenal and gastric ulcers.Gut, 1967
- Gastric ulcers, blood groups, and acid secretionGut, 1964
- Isolation of a Crystalline Trypsin Inhibitor-Anticoagulant Protein from Pancreas1aJournal of the American Chemical Society, 1948